Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Algeria launches large lung cancer registry to improve care

NCT ID NCT07161882

Knowledge-focused Sponsor: Société Algérienne de Formation et de Recherche en Oncologie Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study is a registry that will collect information from about 3,750 adults with lung cancer across 21 hospitals in Algeria. Researchers will track patients' health, treatments, and outcomes during routine care. The goal is to better understand lung cancer in Algeria and help improve future care and health planning.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this registry could provide real-world data to improve lung cancer management and guide health policies in Algeria.
What could go wrong
This is an observational study, not a treatment trial. It collects data only and will not directly test or provide any new therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 3,750 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients diagnosed with lung cancer (NSCLC, SCLC, or carcinoid tumors), recruited across 21 public or university hospitals in Algeria. Patients must have been diagnosed within 12 months prior to inclusion and be managed entirely within the public healthcare system.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years * Histologically confirmed diagnosis of lung cancer (NSCLC, SCLC, or carcinoid tumor) * Diagnosed at the time of inclusion or within the 12 previous months * Fully managed (diagnosis, treatment, and follow-up) in an oncology or pulmonology department of one of the 21 participating public/university hospitals * Signed informed consent obtained Exclusion Criteria: * Prior enrollment in this study * Participation in an interventional clinical trial

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Carcinoid tumor are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

carcinoid tumor lung neoplasm non-small cell lung carcinoma small cell carcinoma small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Carcinoid tumor Carcinoma, non-small-cell lung Carcinoma, small cell Lung neoplasms

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    21 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CAC El OUED

    RECRUITING

    El Oued, Oued Souf, 39000, Algeria

  • CAC Oran EL HASSI- EMIR ABDELKADER

    RECRUITING

    Oran, Oran Province, 31000, Algeria

  • CAC- Ouargla

    RECRUITING

    Ouargla, Ouargla Province, 30000, Algeria

  • CAC- Sidi Bel Abbès

    RECRUITING

    Sidi Bel Abbes, Sidi Bel Abbès Province, 22000, Algeria

  • CAC-CHU Frantz Fanon

    RECRUITING

    Blida, Blida Province, Algeria

  • CAC-Laghouat

    RECRUITING

    Laghouat, Laghouat Province, 03000, Algeria

  • CAC-Sétif

    RECRUITING

    Sétif, Sétif Province, 19000, Algeria

  • CHU Dr Abdesselam Benbadis

    RECRUITING

    Constantine, Constantine Province, 25000, Algeria

  • CHU Dr. Benaouda Benzerdjeb

    RECRUITING

    Oran, Oran Province, 31000, Algeria

  • CHU Mohamed Lamine Debaghine - Bab-el-Oued

    RECRUITING

    Algiers, Algiers Province, 16000, Algeria

  • CHU- Hôpital Khelil Amrane

    RECRUITING

    Béjaïa, Béjaia Province, 06000, Algeria

  • CLCC Annaba

    RECRUITING

    Annaba, Annaba, 23000, Algeria

  • CLCC Batna

    RECRUITING

    Batna City, Batna, Algeria

  • CLCC Draâ Ben Khedda

    RECRUITING

    Tizi Ouzou, Draâ Ben Khedda, 15100, Algeria

  • Centre Pierre et Marie Curie

    RECRUITING

    Algiers, Algiers Province, 16000, Algeria

  • Chu Beni Messous - Isaad Hassani

    RECRUITING

    Algiers, Algiers Province, 16000, Algeria

  • Chu-Beni Messous - Isaad Hassani

    RECRUITING

    Algiers, Algiers Province, 16000, Algeria

  • EH Didouche Mourad

    RECRUITING

    Constantine, Constantine Province, 25000, Algeria

  • EHS 1er novembre

    RECRUITING

    Oran, Oran Province, 31000, Algeria

  • EPH Rouiba

    RECRUITING

    Algiers, Algiers Province, 16000, Algeria

  • EPH- Sidi Ghiles

    RECRUITING

    Tipasa, Sidi Ghiles, 42115, Algeria

More trials for these conditions

Other studies related to the condition(s) this trial covers.